NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

Verkleij, C. P. M., Frerichs, K. A., Broekmans, M. E. C., Duetz, C., O'Neill, C. A., Bruins, W. S. C., Homan-Weert, P. M., Minnema, M. C., Levin, M-D., Broijl, A., Bos, G. M. J., Kersten, M. J., Klein, S. K., Shikhagaie, M. M., Casneuf, T., Abraham, Y., Smets, T., Vanhoof, G., Cortes-Selva, D., van Steenbergen, L., & 7 othersRamos, E., Verona, R. I., Krevvata, M., Sonneveld, P., Zweegman, S., Mutis, T. & van de Donk, N. W. C. J., 2 May 2023, In: HemaSphere. 7, 5, p. E881

Research output: Contribution to journal › Article › Academic › peer-review

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA

van de Donk, N. W. C. J., O’Neill, C., de Ruijter, M. E. M., Verkleij, C. P. M. & Zweegman, S., 1 Nov 2023, In: Current opinion in oncology. 35, 6, p. 601-611 11 p.

Research output: Contribution to journal › Review article › Academic › peer-review